Electromagnetic interference: Pacemakers, cardiac resynchronization therapy devices, implantable cardioverter–defibrillator

被引：2
作者：
Nowak B. [1 ]
Przibille O. [1 ]
Napp A. [2 ]
机构：
[1] Cardioangiologisches Centrum Bethanien, Im Prüfling 23, Frankfurt a.M.
[2] Medizinische Klinik I, – Kardiologie, Angiologie und Internistische Intensivmedizin, Uniklinik RWTH Aachen, Pauwelsstraße 30, Aachen
来源：
Herzschrittmachertherapie + Elektrophysiologie | 2022年 / 33卷 / 3期
关键词：
Cardiac arrhythmias; Cardiac implantable electronic devices; Cardiac pacemaker; Electromagnetic fields; Electromagnetic interference;
D O I：
10.1007/s00399-022-00875-7
中图分类号：
学科分类号：
摘要：
Patients with cardiac pacemakers, implantable cardioverter–defibrillators (ICDs), and cardiac resynchronization therapy devices (CRT) are exposed to different types of electromagnetic interference (EMI) at home and at work. Due to the constantly increasing role of electrically active appliances in daily use and the introduction of new therapy concepts such as the leadless cardiac pacemaker and the subcutaneous defibrillator, this topic is of great relevance. The further development of the implanted devices and the almost complete use of bipolar leads has reduced the overall risk of EMI. This review article provides information about the current status of possible interference in the private environment and how to avoid it. In addition, information is provided on how to deal with occupational sources of interference. © 2022, The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature.
引用
收藏
页码：297 / 304
页数：7
相关论文
共 34 条
  • [1] Boersma L., Barr C., Knops R., Et al., Implant and midterm outcomes of the subcutaneous Implantable cardioverter-defibrillator registry, J Am Coll Cardiol, 70, pp. 830-841, (2017)
  • [2] Burke M.C., Gold M.R., Knight B.P., Et al., Safety and efficacy of the totally subcutaneous Implantable defibrillator, J Am Coll Cardiol, 65, pp. 1605-1615, (2015)
  • [3] Burri H., Mondouagne Engkolo L.P., Dayal N., Et al., Low risk of electromagnetic interference between smartphones and contemporary implantable cardioverter defibrillators, Europace, 18, pp. 726-731, (2016)
  • [4] Censi F., Mattei E., Onder G., Calcagnini G., iphone 12 magsafe technology and cardiac implantable devices: assessment of the actual risk, Pacing Clin Electrophysiol, 45, pp. 410-417, (2022)
  • [5] Chatterjee D., Interaction of iPhone 12 with cardiac implantable electronic devices: is it of any clinical concern?, EP Eur, 24, pp. 179-180, (2022)
  • [6] Fetter J.G., Benditt D.G., Stanton M.S., Electromagnetic interference from welding and motors on implantable cardioverter-defibrillators as tested in the electrically hostile work site, J Am Coll Cardiol, 28, pp. 423-427, (1996)
  • [7] Greenberg J.C., Altawil M.R., Singh G., Letter to the editor—lifesaving therapy inhibition by phones containing magnets, Heart Rhythm, (2021)
  • [8] Groh W.J., Boschee S.A., Engelstein E.D., Et al., Interactions between electronic article surveillance systems and Implantable cardioverter-defibrillators, Circulation, 100, pp. 387-392, (1999)
  • [9] Hayes D.L., Wang P.J., Reynolds D.W., Et al., Interference with cardiac pacemakers by cellular telephones, N Engl J Med, 336, pp. 1473-1479, (1997)
  • [10] Hekmat K., Interference by cellular phones with permanent implanted pacemakers: an update*1, Europace, 6, pp. 363-369, (2004)
1234